Skip to main content

Table 1 MDS patients’ characteristics

From: TET2 is upregulated during erythroid differentiation of CD34+ cells from healthy donors and myelodysplastic syndrome patients

Factors Number
Gender, n (%)
 Male 6
 Female 1
Age y, median (range) 67 (36–75)
Bone marrow blasts (%), median (range) 2.5 (0–4.5)
WHO 2008
 RCMD/RARS 6/1
Karyotype, n
 Normal 7
Peripheral blood counts, median (range)
 Hemoglobin, g/dL 12.8 (7.0–14.2)
 Neutrophils, ×109/L 1.1 (0.2–1.7)
 Platelet count, ×109/L 112 (39–259)
  1. Abbreviations: MDS, myelodysplastic syndromes; WHO, World Health Organization; RCMD, refractory cytopenia with multilineage dysplasia; RARS, refractory anemia with ringed sideroblasts